| AGALSIDASE ALFA (GHU) AND BETA (RCH) INFUSIONS, LITERATURE REVIEW |
Fabrazyme® |
- Shire Australia Pty Ltd
- Genzyme Australasia Pty Ltd
|
|
Nov 2009 |
|
| ALGLUCOSIDASE ALFA |
Myozyme® |
Genzyme |
|
Nov 2009 |
|
| APREPITANT |
Emend® |
Merck Sharp & Dohme (Australia) Pty Ltd |
|
Nov 2009 |
|
| BOTULINUM TOXIN TYPE A PURIFIED NEUROTOXIN COMPLEX |
Botox® |
Allergan Australia Pty Ltd |
|
Nov 2009 |
|
| DABIGATRAN ETEXILATE MESILATE |
Pradaxa® |
Boehringer Ingelheim Pty Ltd |
|
Nov 2009 |
|
| DARUNAVIR |
Prezista® |
Janssen-Cilag Pty Ltd |
|
Nov 2009 |
|
| DICLOFENAC SODIUM WITH MISOPROSTOL |
Arthrote®c |
Pfizer Australia Pty Ltd |
|
Nov 2009 |
|
| DOCETAXEL |
Taxotere® |
sanofi-aventis Australia Pty Ltd |
|
Nov 2009 |
|
| DUTASTERIDE |
Avodart® |
GlaxoSmithKline Australia Pty Ltd |
|
Nov 2009 |
|
| EVEROLIMUS |
Afinitor® |
Novartis Pharmaceuticals Australia Pty Limited |
|
Nov 2009 |
|
| GANIRELIX |
Orgalutran® |
Schering-Plough Pty Ltd |
|
Nov 2009 |
|
| GOSERELIN ACETATE |
Zoladex Implant® |
AstraZeneca Pty Ltd |
|
Nov 2009 |
|
| IMATINIB |
Glivec® |
Novartis Pharmaceuticals Australia Pty Limited |
|
Nov 2009 |
|
| LACOSAMIDE |
Vimpat® |
UCB Australia Proprietary Limited |
|
Nov 2009 |
|
| MARAVIROC |
Celsentri® |
Pfizer Australia Pty Ltd |
|
Nov 2009 |
|
| METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA |
Mircera® |
Roche Products Pty Ltd |
|
Nov 2009 |
|
| NEBIVOLOL HYDROCHLORIDE |
Nebilet® |
CSL Limited |
|
Nov 2009 |
|
| OMALIZUMAB (RCH) |
Xolair® |
Novartis Pharmaceuticals Australia Pty Limited |
|
Nov 2009 |
|
| PEMETREXED DISODIUM |
Alimta® |
Eli Lilly Australia Pty Ltd |
|
Nov 2009 |
|
| RIZATRIPTAN BENZOATE |
Maxalt® |
Merck Sharp & Dohme (Australia) Pty Ltd |
|
Nov 2009 |
|
| TENOFOVIR DISOPROXIL FUMARATE WITH EMTRICITABINE AND EFAVIRENZ |
Atripla® |
Gilead Sciences Pty Limited |
|
Nov 2009 |
|
| TOCILIZUMAB |
Actemra® |
Roche Products Pty Ltd |
Severe active rheumatoid arthritis |
Nov 2009 |
|
| USTEKINUMAB (RMC) |
Stelara® |
Janssen-Cilag Pty Ltd |
|
Nov 2009 |
|
| VARENICLINE TARTRATE |
Champix® |
Pfizer Australia Pty Ltd |
|
Nov 2009 |
|
| ZOLEDRONIC ACID |
Aclasta® |
Novartis Pharmaceuticals Australia Pty Limited |
Corticosteroid-induced osteoporosis (CIO) |
Nov 2009 |
|
| ZOLEDRONIC ACID |
Aclasta® |
Novartis Pharmaceuticals Australia Pty Limited |
Paget disease |
Nov 2009 |
|
| ZOLEDRONIC ACID |
Aclasta® |
Novartis Pharmaceuticals Australia Pty Limited |
Osteoporosis; Bone mineral density (BMD) |
Nov 2009 |
|